Pancreatic Insulinoma: A Case Report
Published: 2023-10-18
Page: 522-527
Issue: 2023 - Volume 6 [Issue 2]
Conde Abraham Youssef
Department of Surgery, Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University in Rabat, Morocco.
Ouhammou Yousra *
Department of Surgery, Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University in Rabat, Morocco.
Kaba Ibrahima
Department of Surgery, Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University in Rabat, Morocco.
Bakunda Cristian
Department of Surgery, Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University in Rabat, Morocco.
Yakka Mbarek
Department of Surgery, Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University in Rabat, Morocco.
Fahsi Mohammed
Department of Surgery, Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University in Rabat, Morocco.
Abouelalaa Khalil
Department of Anesthesiology and Intensive Care, Head of the Operating Room Theatre Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University in Rabat, Morocco.
Elhjouji Abderrahmane
Department of Surgery, Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University in Rabat, Morocco.
Ait Ali Abdelmounaim
Department of Surgery, Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University in Rabat, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Insulinoma is a rare endocrine tumor of the pancreas. cause of organic hypoglycemia, and is life-threatening if left untreated; The diagnosis is made in the presence of more or less characteristic but non-specific symptoms. Confirmation of the diagnosis is biological. However, morphological exploration by means of computed tomography (CT) objectifies pancreatic insulinoma. Surgical treatment of the tumor ensures a cure, usually definitive in the case of benign tumors.
Insulinoma remains a diagnostic challenge for health care practitioners. Nevertheless, thanks to an enhanced understanding of its clinical, biological, and histoprognostic characteristics, therapeutic options have advanced in recent years, notably through the development of laparoscopic surgery.
Keywords: Pancreatic insulinoma, hypoglycemia, surgical treatment, multiple endocrine neoplasias
How to Cite
Downloads
References
Vaidakis D, Karoubalis J, Pappa T, et al. Pancreaticinsulinoma: current issues and trends. HepatobiliaryPancreat Dis Int. 2010;9(3):234–241.
Marx S, Spiegel AM, Skarulis MC, et al. Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med. 1998;129:484.
Gouya H, Vignaux O, Augui J, et al. Endoscopicsonography and a combinedprotocol for preoperativeevaluation of pancreaticinsulinomas. AJR Am J Roentgenol. 2003;181:987–992.
Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adulthypoglycemicdisorders: an endocrine society clinical practice guideline. J Clin EndocrinolMetab. 2009;94:709–728.
Quinkler M, Strelow F, Pirlich M, et al. Assessment of suspectedinsulinoma by 48-hour fastingtest: aretrospective monocentric study of 23 cases. HormMetabRes. 2007;39:507–510.
Van Bon AC, Benhadi N, Endert E. Evaluation of endocrine tests: the prolongedfasting test for insulinoma. Neth J Med. 2009;67:274–278.
Agin A, Charrie A, Chikh K. Fast test: clinical practice and interpretation. Ann Endocrinol. 2013;74:174–184.
Azimuddin K, Chamberlain RS. The surgical management of pancreatic neuroendocrine tumors. Surg Clin North Am. 2001;81:5125.
Crinò SF, Partelli S, Napoleon B, Bellocchi MC, Facciorusso A, Salvia R, Forti E, Cintolo M, Mazzola M, Ferrari G, Carrara S. Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma. Digestive and Liver Disease. 2023;55(9):1187-93.
Calender A. Génétique des tumeurs neuroendocrines. Rev Prat. 2002;52:256–261.
Guerrero-Pérez F, Vilarrasa N, Huánuco LV, Busquets J, Secanella L, Vercher-Conejero JL, Vidal N, Näf Cortés S, Villabona C. Ectopic insulinoma : a systematic review. Reviews in Endocrine and Metabolic Disorders. 2023:1-2.
Suzuki K, Miyamoto M, Miyamoto T. Insulinomawithearlymorningabnormalbehavior. Intern Med. 2007;46:405–408.
Therasse E, Taillefer R. Imaging of endocrine tumors of the pancreas. Ann Endocrinol. 1995;56:509–510.
Owen NJ, Sohaieb SAA, Peppercorn PD, et al. MRI of pancreatic neuroendocrine tumors. BJR. 2002;74:968–973.
Gualdi GF, Casciani E, Polettini E. Imaging of neuroendocrine tumors. Clin Ter. 2001;152(2):107–121.
Iihara M, Kanbe M, Okamoto T, et al. Laparoscopicultrasonography for resection of insulinomas. Surgery. 2001;130:1086–1091.
Reubi JC, Waser B. Concomitant expression of several peptide receptors in neuroendocrine tumors: molecular basis for in vivo multi-receptortumortargeting. Eur J Nucl Med Mol Imaging. 2003;30:781–793.
Biermann MR, Sundar P, Veeramachaneni H, Chawla S, Patel V, Orr J, Keilin S, Willingham FF. Radiofrequency Ablation for the Management of Symptomatic Pancreatic Insulinomas. VideoGIE; 2023.
Placzkowski KA, Vella A, Thompson GB, et al. Secular trends in the presentation and management of functioninginsulinoma at the Mayo Clinic, 1987–2007. J Clin EndocrinolMetab. 2009;94:1069–1073.